| Ytd | -52.64% | |
| 1y | 40.00% |
| Open | 6.52 | Prev Close | 6.84 | Low | 6.46 | High | 6.91 | Mkt Cap | 24.27M |
| Vol | 111.44K | Avg Vol | 2.17M | EPS | -17.19 | P/E | -0.39 | Forward P/E | -0.66 |
| Beta | 1.27 | Short Ratio | 1.89 | Inst. Own | 57.52% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-04 | 50-d Avg | 3.54 | 200-d Avg | 9.38 | 1yr Est | 3.33 |
Additional financing from a world-class investor syndicate further strengthens the combined company'
Gainers AbCellera Biologics (NASDAQ:ABCL) shares increased by 8.2% to $7.5 during Friday's afte
NextCure (NASDAQ:NXTC) reported quarterly losses of $(2.80) per share which missed the analyst conse
Gainers Autonomix Medical (NASDAQ:AMIX) stock rose 415.3% to $18.81 during Tuesday's regular se
Gainers Autonomix Medical (NASDAQ:AMIX) stock rose 49.1% to $4.1 during Tuesday's after-market
Gainers Entera Bio (NASDAQ:ENTX) stock moved upwards by 86.6% to $3.83 during Monday's regular
NextCure, Inc. (NASDAQ: NXTC - Get Free Report) was the target of a large increase in short interest
Gainers China SXT Pharmaceuticals (NASDAQ:SXTC) shares moved upwards by 41.1% to $0.09 during Frida
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following compan
NEW YORK, July 23, 2026 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde &
$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--VEEE, NXTC, TCBK
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following compan
NEW YORK, July 21, 2026 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde &
MILWAUKEE, July 21, 2026 (GLOBE NEWSWIRE) -- Ademi LLP is investigating NextCure (NASDAQ: NXTC) for
Gainers Ernexa Therapeutics (NASDAQ:ERNA) stock increased by 88.3% to $11.41 during Wednesday's
Shares of Aehr Test Systems (NASDAQ: AEHR) jumped 29.6% to $93.30 in pre-market trading. Aehr Test
Gainers Exicure (NASDAQ:XCUR) stock rose 38.4% to $2.38 during Tuesday's after-market session.
NextCure Inc. (NASDAQ:NXTC) on Tuesday agreed to merge with privately held biotechnology company Ave
NextCure will merge with Avere in a $320 million exchange to advance oral IL-23 therapy AVR-001 and
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of NextCure, Inc. (NASDAQ: N
NEW YORK, July 14, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Asso
Gainers NextCure (NASDAQ:NXTC) stock increased by 201.4% to $6.57 during Tuesday's regular sess
Stocks mixed, Dow falls over 100 points. Nasdaq up 0.88%, S&P up 0.32%. Tech shares surge 1.2%,
Shareholder Alert: Ademi LLP investigates whether NextCure, Inc. is obtaining a Fair Price for Publi
MILWAUKEE, July 14, 2026 /PRNewswire/ -- Ademi LLP is investigating NextCure (NASDAQ: NXTC) for poss
Halper Sadeh LLC, an investor rights law firm, is investigating the merger of NextCure, Inc. (NASDAQ
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the merge
US stocks rise, Nasdaq gains 100 points. Dow up 0.18%, Nasdaq up 0.49%, S&P 500 up 0.26%. Materi
Gainers NextCure (NASDAQ:NXTC) shares rose 305.5% to $8.84 during Tuesday's pre-market session.
NextCure, Inc. (NASDAQ:NXTC) ("NextCure") and Avere Therapeutics, Inc. ("Avere"), a
Avere Therapeutics' lead program, AVR-001, is a differentiated oral peptide interleukin-23 (IL-23) r
Gainers OSR Health (NASDAQ:OSRH) stock increased by 7.2% to $0.33 during Wednesday's after-mark
Oncology innovation is reshaping cancer care as AI, immunotherapy and targeted therapies fuel pipeli
BELTSVILLE, Md., June 04, 2026 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage b
NextCure, Inc. (NXTC) Discusses Preliminary Phase I Data for SIM0505 in Platinum-Resistant Ovarian C
55% ORR in gynecologic cancers with 52.9% in ovarian and 66.7% in USC at 12 weeks by best response p
U.S. stock futures swung between gains and losses on Friday after ending on a mixed note on Thursday
On Monday, 79 companies reached new 52-week lows.
On Monday, 413 companies reached new 52-week lows.
On Friday morning, 446 companies hit new 52-week lows.
Monday saw 825 companies set new 52-week lows.
On Wednesday, 807 companies reached new 52-week lows.
During Wednesday's trading, 435 companies set new 52-week lows.
During Thursday, 849 stocks hit new 52-week lows.
Wednesday's session saw 784 companies set new 52-week lows.